ethinyl estradiol has been researched along with lamotrigine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Brodtkorb, E; Helde, G; Reimers, A | 1 |
| Job, S; Philipson, R; Sidhu, J; Singh, S | 1 |
| Atterman, J; Christensen, J; Ohman, I; Petrenaite, V; Sabers, A; Sidenius, P; Tomson, T | 1 |
| Reimers, A; Skogvoll, E; Spigset, O; Sund, JK | 1 |
| Fujii, Y; Kusumi, I; Sawagashira, R | 1 |
1 review(s) available for ethinyl estradiol and lamotrigine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
1 trial(s) available for ethinyl estradiol and lamotrigine
| Article | Year |
|---|---|
Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Interactions; Epilepsy; Ethinyl Estradiol; Female; Glucuronides; Humans; Lamotrigine; Placebos; Triazines | 2007 |
10 other study(ies) available for ethinyl estradiol and lamotrigine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
Topics: Anticonvulsants; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Humans; Lamotrigine; Progestins; Triazines | 2005 |
The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.
Topics: Adolescent; Adult; Anticonvulsants; Contraceptives, Oral, Combined; Drug Interactions; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Lamotrigine; Levonorgestrel; Luteinizing Hormone; Middle Aged; Ovulation; Sex Hormone-Binding Globulin; Triazines | 2006 |
Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Antidepressive Agents; Benzodiazepines; Child; Child, Preschool; Contraceptives, Oral, Combined; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; Fluoxetine; Humans; Lamotrigine; Male; Models, Biological; Triazines; Valproic Acid | 2007 |
Clinical pharmacokinetic interactions between lamotrigine and hormonal contraceptives in bipolar I disorder.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Contraceptives, Oral, Hormonal; Drug Interactions; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Lamotrigine; Norethindrone; Triazines; Young Adult | 2017 |